Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
PMTS Quote, Financials, Valuation and Earnings
Last price:
$21.74
Seasonality move
:
2.98%
Day range:
$21.19 - $21.86
52-week range:
$18.46 - $35.19
Dividend yield:
0%
P/E ratio:
13.70x
P/S ratio:
0.53x
P/B ratio:
--
Volume:
48.7K
Avg. volume:
51.2K
1-year change:
-26.56%
Market cap:
$245.8M
Revenue:
$480.6M
EPS (TTM):
$1.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $312.2M | $375.1M | $475.7M | $444.5M | $480.6M | |
| Revenue Growth (YoY) | 12.27% | 20.16% | 26.83% | -6.56% | 8.11% | |
| Cost of Revenues | $201.9M | $233.7M | $300M | $289.1M | $309.4M | |
| Gross Profit | $110.3M | $141.4M | $175.8M | $155.5M | $171.2M | |
| Gross Profit Margin | 35.33% | 37.7% | 36.95% | 34.98% | 35.63% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $65.8M | $75.7M | $90.8M | $88.3M | $103.4M | |
| Other Inc / (Exp) | -$109K | -$5M | -$367K | -$215K | -$3.7M | |
| Operating Expenses | $71.9M | $82M | $96.6M | $93.9M | $108.4M | |
| Operating Income | $38.4M | $59.5M | $79.1M | $61.6M | $62.8M | |
| Net Interest Expenses | $25.4M | $30.6M | $29.6M | $26.9M | $34.1M | |
| EBT. Incl. Unusual Items | $12.9M | $23.8M | $49.1M | $34.5M | $25M | |
| Earnings of Discontinued Ops. | -$61K | -- | -- | -- | -- | |
| Income Tax Expense | -$3.3M | $7.9M | $12.6M | $10.5M | $5.5M | |
| Net Income to Company | $16.1M | $15.9M | $36.5M | $24M | $19.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $16.1M | $15.9M | $36.5M | $24M | $19.5M | |
| Basic EPS (Cont. Ops) | $1.44 | $1.42 | $3.24 | $2.10 | $1.75 | |
| Diluted EPS (Cont. Ops) | $1.44 | $1.36 | $3.11 | $2.01 | $1.64 | |
| Weighted Average Basic Share | $11.2M | $11.2M | $11.3M | $11.4M | $11.2M | |
| Weighted Average Diluted Share | $11.2M | $11.8M | $11.7M | $11.9M | $11.9M | |
| EBITDA | $55.1M | $74.6M | $93.6M | $77.5M | $79.2M | |
| EBIT | $38.3M | $59.5M | $78.8M | $61.6M | $62.8M | |
| Revenue (Reported) | $312.2M | $375.1M | $475.7M | $444.5M | $480.6M | |
| Operating Income (Reported) | $38.4M | $59.5M | $79.1M | $61.6M | $62.8M | |
| Operating Income (Adjusted) | $38.3M | $59.5M | $78.8M | $61.6M | $62.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $89.1M | $111.4M | $120.9M | $111.9M | $122.8M | |
| Revenue Growth (YoY) | 20.45% | 25.07% | 8.46% | -7.38% | 9.67% | |
| Cost of Revenues | $53.4M | $72.1M | $77.8M | $70.4M | $82.1M | |
| Gross Profit | $35.7M | $39.3M | $43.1M | $41.5M | $40.7M | |
| Gross Profit Margin | 40.1% | 35.25% | 35.66% | 37.09% | 33.15% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.1M | $19.9M | $21.1M | $26M | $25.5M | |
| Other Inc / (Exp) | -$5M | -$396K | -$114K | -$65K | $18K | |
| Operating Expenses | $18M | $21.3M | $22.5M | $27.4M | $26.6M | |
| Operating Income | $17.8M | $18M | $20.6M | $14.1M | $14.1M | |
| Net Interest Expenses | $9M | $7.9M | $6.8M | $6.4M | $7.7M | |
| EBT. Incl. Unusual Items | $3.8M | $9.7M | $13.7M | $7.7M | $6.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $3.7M | $2.8M | $2.2M | $1.7M | |
| Net Income to Company | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Basic EPS (Cont. Ops) | $0.21 | $0.53 | $0.95 | $0.48 | $0.42 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.51 | $0.91 | $0.46 | $0.40 | |
| Weighted Average Basic Share | $11.2M | $11.3M | $11.4M | $11.3M | $11.2M | |
| Weighted Average Diluted Share | $11.6M | $11.7M | $11.9M | $11.8M | $12M | |
| EBITDA | $17M | $21.2M | $24.3M | $18.2M | $18.4M | |
| EBIT | $12.7M | $17.6M | $20.5M | $14.1M | $14.1M | |
| Revenue (Reported) | $89.1M | $111.4M | $120.9M | $111.9M | $122.8M | |
| Operating Income (Reported) | $17.8M | $18M | $20.6M | $14.1M | $14.1M | |
| Operating Income (Adjusted) | $12.7M | $17.6M | $20.5M | $14.1M | $14.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $327.3M | $397.5M | $485.2M | $435.6M | $491.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $206.9M | $252.5M | $305.6M | $281.7M | $321M | |
| Gross Profit | $120.4M | $145M | $179.6M | $153.9M | $170.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $65.3M | $79.4M | $92M | $93.2M | $102.9M | |
| Other Inc / (Exp) | -$5M | -$407K | -$85K | -$166K | -$3.6M | |
| Operating Expenses | $71.7M | $85.3M | $97.8M | $98.8M | $107.6M | |
| Operating Income | $48.7M | $59.7M | $81.7M | $55.1M | $62.8M | |
| Net Interest Expenses | $28.3M | $29.5M | $28.5M | $26.6M | $35.3M | |
| EBT. Incl. Unusual Items | $15.3M | $29.8M | $53.1M | $28.4M | $23.8M | |
| Earnings of Discontinued Ops. | -$35K | -- | -- | -- | -- | |
| Income Tax Expense | -$1.5M | $10.2M | $11.7M | $9.8M | $5M | |
| Net Income to Company | $16.8M | $19.5M | $41.4M | $18.6M | $18.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $16.8M | $19.5M | $41.4M | $18.6M | $18.8M | |
| Basic EPS (Cont. Ops) | $1.49 | $1.73 | $3.66 | $1.63 | $1.69 | |
| Diluted EPS (Cont. Ops) | $1.48 | $1.66 | $3.50 | $1.56 | $1.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $60.4M | $78.8M | $96.7M | $71.5M | $79.5M | |
| EBIT | $43.6M | $64.3M | $81.7M | $55.3M | $62.9M | |
| Revenue (Reported) | $327.3M | $397.5M | $485.2M | $435.6M | $491.4M | |
| Operating Income (Reported) | $48.7M | $59.7M | $81.7M | $55.1M | $62.8M | |
| Operating Income (Adjusted) | $43.6M | $64.3M | $81.7M | $55.3M | $62.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $89.1M | $111.4M | $120.9M | $111.9M | $122.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $53.4M | $72.1M | $77.8M | $70.4M | $82.1M | |
| Gross Profit | $35.7M | $39.3M | $43.1M | $41.5M | $40.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.1M | $19.9M | $21.1M | $26M | $25.5M | |
| Other Inc / (Exp) | -$5M | -$396K | -$114K | -$65K | $18K | |
| Operating Expenses | $18M | $21.3M | $22.5M | $27.4M | $26.6M | |
| Operating Income | $17.8M | $18M | $20.6M | $14.1M | $14.1M | |
| Net Interest Expenses | $9M | $7.9M | $6.8M | $6.4M | $7.7M | |
| EBT. Incl. Unusual Items | $3.8M | $9.7M | $13.7M | $7.7M | $6.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $3.7M | $2.8M | $2.2M | $1.7M | |
| Net Income to Company | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Basic EPS (Cont. Ops) | $0.21 | $0.53 | $0.95 | $0.48 | $0.42 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.51 | $0.91 | $0.46 | $0.40 | |
| Weighted Average Basic Share | $11.2M | $11.3M | $11.4M | $11.3M | $11.2M | |
| Weighted Average Diluted Share | $11.6M | $11.7M | $11.9M | $11.8M | $12M | |
| EBITDA | $17M | $21.2M | $24.3M | $18.2M | $18.4M | |
| EBIT | $12.7M | $17.6M | $20.5M | $14.1M | $14.1M | |
| Revenue (Reported) | $89.1M | $111.4M | $120.9M | $111.9M | $122.8M | |
| Operating Income (Reported) | $17.8M | $18M | $20.6M | $14.1M | $14.1M | |
| Operating Income (Adjusted) | $12.7M | $17.6M | $20.5M | $14.1M | $14.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $57.6M | $20.7M | $11M | $12.4M | $33.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $44.3M | $50M | $68.9M | $69.2M | $78.5M | |
| Inventory | $24.8M | $58M | $68.4M | $70.6M | $72.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5M | -- | $7.6M | $8.6M | $11.3M | |
| Total Current Assets | $152.5M | $145.7M | $167.6M | $165.4M | $203M | |
| Property Plant And Equipment | $39.4M | $47.3M | $57.2M | $63.1M | $68.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $47.2M | $47.2M | $47.2M | $47.2M | $47.2M | |
| Other Intangibles | $26.2M | $21.9M | $18M | $14.1M | $10.5M | |
| Other Long-Term Assets | $857K | $6.2M | $6.8M | $4M | $20.3M | |
| Total Assets | $266.2M | $268.1M | $296.7M | $293.7M | $349.7M | |
| Accounts Payable | $18.9M | $26.4M | $24.4M | $12.8M | $16.1M | |
| Accrued Expenses | $14.1M | $23.2M | $24.1M | $27.5M | $35.4M | |
| Current Portion Of Long-Term Debt | $8M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.4M | $4.1M | $5.7M | $7.3M | $9.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $56.9M | $64.8M | $68M | $49.4M | $75.6M | |
| Long-Term Debt | $328.7M | $303.6M | $285.5M | $265M | $280.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $404.2M | $389.2M | $378.7M | $345.6M | $385.3M | |
| Common Stock | $11K | $11K | $11K | $11K | $11K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$138M | -$121M | -$82.1M | -$51.9M | -$35.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$138M | -$121M | -$82.1M | -$51.9M | -$35.6M | |
| Total Liabilities and Equity | $266.2M | $268.1M | $296.7M | $293.7M | $349.7M | |
| Cash and Short Terms | $57.6M | $20.7M | $11M | $12.4M | $33.5M | |
| Total Debt | $336.7M | $303.6M | $285.5M | $265M | $280.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.9M | $12.1M | $14.2M | $17.1M | $31.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $49.7M | $59.5M | $64.9M | $59.8M | $67M | |
| Inventory | $33.5M | $70.5M | $69.7M | $83.4M | $75.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.2M | $6.2M | $8.2M | $11.9M | $10.3M | |
| Total Current Assets | $133.2M | $160M | $168.3M | $180.9M | $192.6M | |
| Property Plant And Equipment | $38.2M | $50M | $60.2M | $61M | $80.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $47.2M | $47.2M | $47.2M | $47.2M | $47.2M | |
| Other Intangibles | $25.1M | $20.9M | $17M | $13.2M | $9.6M | |
| Other Long-Term Assets | $2.7M | $7.7M | $5.5M | $17.5M | $22.3M | |
| Total Assets | $246.3M | $285.7M | $298.2M | $319.8M | $351.9M | |
| Accounts Payable | $21.8M | $30.4M | $25.9M | $23.6M | $22.1M | |
| Accrued Expenses | $11.9M | $20M | $20.1M | $23.6M | $25.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4M | $5.1M | $6M | $7.2M | $9.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $45.7M | $60.6M | $57.5M | $74M | $65.2M | |
| Long-Term Debt | $317.5M | $314.4M | $286M | $265.3M | $280.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $381.9M | $399.8M | $368.9M | $368.2M | $381.6M | |
| Common Stock | $11K | $11K | $11K | $11K | $11K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$135.6M | -$114.1M | -$70.7M | -$48.5M | -$29.7M | |
| Total Liabilities and Equity | $246.3M | $285.7M | $298.2M | $319.8M | $351.9M | |
| Cash and Short Terms | $24.9M | $12.1M | $14.2M | $17.1M | $31.5M | |
| Total Debt | $317.5M | $314.4M | $286M | $265.3M | $280.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.1M | $15.9M | $36.5M | $24M | $19.5M | |
| Depreciation & Amoritzation | $16.8M | $15.1M | $14.9M | $15.9M | $16.4M | |
| Stock-Based Compensation | $136K | $1.3M | $3.5M | $7.5M | $8.5M | |
| Change in Accounts Receivable | -$11.7M | -$6.4M | -$19.7M | $6.8M | -$11.8M | |
| Change in Inventories | -$6.1M | -$33.4M | -$10.7M | -$1.6M | -$2M | |
| Cash From Operations | $22M | $20.2M | $31.3M | $34M | $43.3M | |
| Capital Expenditures | $7.1M | $10.1M | $17.9M | $6.4M | $9.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.1M | -$9.9M | -$17.8M | -$6.2M | -$9.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $29.1M | $324.8M | $37.1M | -- | $285M | |
| Long-Term Debt Repaid | -$2.6M | -$359.7M | -$58.3M | -$25.8M | -$273.1M | |
| Repurchase of Common Stock | -- | -- | -- | -$250K | -$8.7M | |
| Other Financing Activities | -$2.5M | -$12.3M | -$1.9M | -$368K | -$16.2M | |
| Cash From Financing | $24M | -$47.2M | -$23.2M | -$26.4M | -$13M | |
| Beginning Cash (CF) | $18.7M | $57.6M | $20.7M | $11M | $12.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $38.9M | -$36.9M | -$9.6M | $1.4M | $21.1M | |
| Ending Cash (CF) | $57.6M | $20.7M | $11M | $12.4M | $33.5M | |
| Levered Free Cash Flow | $14.9M | $10.2M | $13.5M | $27.6M | $34.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Depreciation & Amoritzation | $4.2M | $3.6M | $3.8M | $4M | $4.2M | |
| Stock-Based Compensation | $51K | $961K | $541K | $3.1M | $1.7M | |
| Change in Accounts Receivable | -$5.9M | -$10.3M | $4.3M | $5.2M | $10M | |
| Change in Inventories | -$8.9M | -$12.6M | -$1.5M | -$13M | -$2.5M | |
| Cash From Operations | $144K | -$16M | $8M | $8.9M | $5.6M | |
| Capital Expenditures | $2.5M | $3.2M | $4.1M | $1.5M | $5.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.4M | -$3.1M | -$4.1M | -$1.5M | -$5.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $324.8M | $32.1M | $8M | -- | -- | |
| Long-Term Debt Repaid | -$343.1M | -$20.6M | -$8.7M | -$1.3M | -$1.8M | |
| Repurchase of Common Stock | -- | -- | -- | -$1.3M | -- | |
| Other Financing Activities | -$12.1M | -$862K | -$69K | -$109K | -$541K | |
| Cash From Financing | -$30.5M | $10.6M | -$792K | -$2.6M | -$2.4M | |
| Beginning Cash (CF) | $57.6M | $20.7M | $11M | $12.4M | $33.5M | |
| Foreign Exchange Rate Adjustment | $3K | -- | $6K | -- | -- | |
| Additions / Reductions | -$32.7M | -$8.5M | $3.1M | $4.7M | -$2M | |
| Ending Cash (CF) | $24.9M | $12.1M | $14.2M | $17.1M | $31.5M | |
| Levered Free Cash Flow | -$2.4M | -$19.1M | $3.9M | $7.4M | $292K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.8M | $19.5M | $41.4M | $18.6M | $18.8M | |
| Depreciation & Amoritzation | $16.8M | $14.5M | $15.1M | $16.1M | $16.7M | |
| Stock-Based Compensation | $146K | $2.2M | $3.1M | $10M | $7.2M | |
| Change in Accounts Receivable | -$15.8M | -$10.8M | -$5.1M | $7.6M | -$7M | |
| Change in Inventories | -$15.5M | -$37.1M | $413K | -$13.2M | $8.5M | |
| Cash From Operations | $19M | $4.1M | $55.3M | $34.9M | $40M | |
| Capital Expenditures | $8.7M | $10.7M | $18.9M | $3.8M | $13.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.5M | -$10.7M | -$18.7M | -$3.6M | -$13M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $324.8M | $32.1M | $13M | -$8M | -- | |
| Long-Term Debt Repaid | -$345.1M | -$37.2M | -$46.4M | -$18.4M | -$273.7M | |
| Repurchase of Common Stock | -- | -- | -- | -$1.5M | -$7.4M | |
| Other Financing Activities | -$12.1M | -$1M | -$1.1M | -$408K | -$16.6M | |
| Cash From Financing | -$32.5M | -$6.2M | -$34.5M | -$28.3M | -$12.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$22.1M | -$12.7M | $2.1M | $3M | $14.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $10.3M | -$6.6M | $36.4M | $31.1M | $27M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4M | $6M | $10.9M | $5.5M | $4.8M | |
| Depreciation & Amoritzation | $4.2M | $3.6M | $3.8M | $4M | $4.2M | |
| Stock-Based Compensation | $51K | $961K | $541K | $3.1M | $1.7M | |
| Change in Accounts Receivable | -$5.9M | -$10.3M | $4.3M | $5.2M | $10M | |
| Change in Inventories | -$8.9M | -$12.6M | -$1.5M | -$13M | -$2.5M | |
| Cash From Operations | $144K | -$16M | $8M | $8.9M | $5.6M | |
| Capital Expenditures | $2.5M | $3.2M | $4.1M | $1.5M | $5.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.4M | -$3.1M | -$4.1M | -$1.5M | -$5.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $324.8M | $32.1M | $8M | -- | -- | |
| Long-Term Debt Repaid | -$343.1M | -$20.6M | -$8.7M | -$1.3M | -$1.8M | |
| Repurchase of Common Stock | -- | -- | -- | -$1.3M | -- | |
| Other Financing Activities | -$12.1M | -$862K | -$69K | -$109K | -$541K | |
| Cash From Financing | -$30.5M | $10.6M | -$792K | -$2.6M | -$2.4M | |
| Beginning Cash (CF) | $57.6M | $20.7M | $11M | $12.4M | $33.5M | |
| Foreign Exchange Rate Adjustment | $3K | -- | $6K | -- | -- | |
| Additions / Reductions | -$32.7M | -$8.5M | $3.1M | $4.7M | -$2M | |
| Ending Cash (CF) | $24.9M | $12.1M | $14.2M | $17.1M | $31.5M | |
| Levered Free Cash Flow | -$2.4M | -$19.1M | $3.9M | $7.4M | $292K | |
Get PMTS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PMTS
Sector
P/E ratio
13.70x
23.84x
PEG ratio
7.13x
0.00x
P/B ratio
--
2.31x
Price / LTM sales
0.53x
1.64x
Growth Metrics
PMTS
Sector
Revenue growth
9.67%
3.84%
Earnings growth
-13.04%
10.8%
Revenue (5-year growth)
11.56%
6.27%
Earnings forecast
$0.69
$0.12
Profitability
PMTS
Sector
Profitability FY 2024
$171.2M
$77.3M
Return on invested capital
8.02%
0.05%
Return on assets
5.59%
-0.48%
Return on equity
--
0.73%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
6
Balance Sheet
PMTS
Sector
Total cash
$31.5M
$48.7M
Short term investments
--
$19.4M
Total assets
$349.7M
$223.8M
Long term debt
$280.7M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
